A designed trial based on the New York Heart Association (NYHA) classification system, in which patients considered to have NYHA classes I–IV were observed to have gradually increasing plasma BNP concentrations, suggesting that plasma BNP concentration increases with the severity of HF [77]. The gene discussed is NPPB; the disease is hydrops fetalis.